|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02315 BIOCYTOGEN-B
Nominal 
22.520 -2.180 (-8.826%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 620,963 | 51.270% | 410,499 | 326,836 | 229,131 | 131,055 |
| Cost of Sales | (159,014) | 51.433% | (105,006) | (91,472) | (62,161) | (41,981) |
| Gross Profit | 461,949 | 51.214% | 305,493 | 235,364 | 166,970 | 89,074 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 20,796 | 220.777% | 6,483 | 942 | 10,233 | (13,835) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (11,856) | 30.501% | (9,085) | (4,983) | (9,484) | (224) | |
| Profit / (Loss) before Taxation | 59,620 | -- | (47,077) | (189,389) | (272,593) | (249,276) | |
| Taxation | (11,621) | 223.165% | (3,596) | (420) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 1 | 208 | 2 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 47,999 | -- | (50,673) | (189,808) | (272,385) | (249,274) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 33,566 | -31.887% | 49,280 | 41,160 | 18,187 | 12,336 |
| Depreciation & Amortisation | 85,099 | -0.424% | 85,461 | 84,063 | 77,402 | 45,454 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 12.000 | -- | -13.000 | -48.000 | -73.000 | -69.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.233 | -- | 1.852 | 2.405 | -- | -- |
| Remarks: | Real time quote last updated: 12/09/2025 14:28 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 47,999 |
| %Change | -- |
| EPS / (LPS) | RMB 0.120 |
| NBV Per Share (¥) | RMB 2.233 |